Search
Skip to Search Results- 2Coulombe, Marilyne G.
- 2Kinnaird, Adam
- 2Srivastava, Nutan
- 1Abdualla, Radya Y
- 1Abofayed, Hiatem Abdullah
- 1Aburahess, Salah
- 8Primary Biliary Cholangitis
- 7Inflammatory bowel disease
- 6Inflammatory Bowel Disease
- 5Acute myeloid leukemia
- 5Endothelial cells
- 4B cells
-
Spring 2024
Abstract Advanced cirrhosis is characterized by hemodynamic abnormalies, including increased portal pressure, and decreased arterial pressure, which contribute to the complicaons of the disease4. Short chain faty acids (SCFAs), produced by the gut microbiota through carbohydrate fermentaon,...
-
Deciphering the Biological Basis of Acute Myeloid Leukemia Relapse Using a Novel In-Vitro Study Model
DownloadSpring 2024
Acute myeloid leukemia (AML) is an aggressive hematologic malignancy associated with a poor clinical outcome that is largely attributed to disease relapses. Treatment options for relapsed AML patients are limited; after relapse, the median survival is only ~6 months. The biology underlying...
-
Pharmacist-Led Follow-Up Program for Rural Acute Coronary Syndrome Patients: The PLURAL-ACS Study
DownloadSpring 2024
Background: Rural patients have been shown to have reduced access to care, delayed discharge prescription fills, and frequent readmissions following acute coronary syndrome (ACS) compared to urban patients. While virtual and pharmacist-led programs have shown benefit in providing efficient care...
-
An assessment of Canada’s foreign-born tuberculosis surveillance strategy and insights gained into TB transmission
DownloadSpring 2024
This thesis, comprising three published research papers, examines both Canada's tuberculosis (TB) surveillance strategies among foreign-born individuals and broader TB transmission dynamics. In Canada, a country with low TB incidence, most TB cases occur among the foreign-born population. The...
-
Evaluation of Targeted Selective Inhibitors to Enhance Temozolomide Treatment Sensitivity in Acute Myeloid Leukemia
DownloadSpring 2024
Temozolomide (TMZ) is an alkylating agent with limited activity in acute myeloid leukemia (AML). The DNA repair enzyme O6-methylguanine methyltransferase (MGMT) enhances tumor cell resistance to TMZ. B-cell lymphoma-2 (BCL-2) and mouse double minute 2 homology (MDM2) are proteins involved in AML...